Trial Profile
Pharmacokinetic Study of ORM-12741 After Multiple Oral Doses
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs ORM 12741 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Acronyms Nebula PK 2
- Sponsors Orion
- 05 May 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jan 2015 as per ClinicalTrials.gov record.
- 05 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 04 Dec 2014 New trial record